SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2132435

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132435

Pharmaceutical Stability and Storage Services Market Size, Share & Trends Analysis Report By Service, By Molecule, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 0.065 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Pharmaceutical Stability And Storage Services Market Summary

The global pharmaceutical stability and storage services market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 3.4 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. The market in North America dominated with a revenue share of 40.1% in 2025. Market growth is driven by expanding drug development pipelines, increasing production of biologics & advanced therapies, and mandatory regulatory requirements for shelf-life and storage validation.

Other factors contributing to market growth include rising outsourcing by pharmaceutical and biotechnology companies, increasing clinical trial activity, greater demand for cold- and ultra-low-temperature storage, recurring commercial stability programs, packaging and formulation changes, and the adoption of digital monitoring and compliant sample-management systems.

Global Pharmaceutical Stability And Storage Services Market Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical stability and storage services market report based on service, molecule, and region.

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Stability
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability Testing
    • Photostability Testing
    • Other Stability Testing Methods
  • Storage
    • Cold
    • Non-cold
  • Molecule Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Molecule
    • Research Products
    • Commercial Products
  • Large Molecule
    • Research Products
    • Commercial Products
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman
Product Code: GVR-4-68039-936-6

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Molecule
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Stability and Storage Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High R&D Spending of Pharmaceutical & Biotechnology Companies
      • 3.2.1.2. Rising Demand for Outsourcing Stability Testing Due to High Complexity Associated with Drug Stability
      • 3.2.1.3. Growing Demand for Biosimilars
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Strict Regulations for Global Pharmaceutical Stability and Storage Services Drugs
      • 3.2.2.2. Issues Associated with Stability Chambers
  • 3.3. Business Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Pricing Model Analysis
  • 3.6. Tariff and Trade Agreement Impact Analysis
  • 3.7. Industry Ecosystem Analysis
  • 3.8. Market Analysis Tools
    • 3.8.1. Porter's Five Force Analysis
    • 3.8.2. PESTEL by SWOT Analysis

Chapter 4. Pharmaceutical Stability and Storage Services Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Stability and Storage Services Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Stability and Storage Services Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Stability and Storage Services Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 4.4. Stability
    • 4.4.1. Stability Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Drug Substance
      • 4.4.2.1. Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Stability Indicating Method Validation
      • 4.4.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Accelerated Stability Testing
      • 4.4.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Photostability Testing
      • 4.4.5.1. Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.6. Other Stability Testing Methods
      • 4.4.6.1. Other Stability Testing Methods Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Storage
    • 4.5.1. Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Cold
      • 4.5.2.1. Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Non-Cold
      • 4.5.3.1. Non-Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pharmaceutical Stability and Storage Services Market: Molecule Estimates & Trend Analysis

  • 5.1. Pharmaceutical Stability and Storage Services Market, By Molecule: Segment Dashboard
  • 5.2. Pharmaceutical Stability and Storage Services Market, By Molecule: Movement Analysis
  • 5.3. Pharmaceutical Stability and Storage Services Market Estimates & Forecasts, By Molecule, 2021 - 2033 (USD Million)
  • 5.4. Small Molecule
    • 5.4.1. Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Research Products
      • 5.4.2.1. Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Commercial Products
      • 5.4.3.1. Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Large Molecule
    • 5.5.1. Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Research Products
      • 5.5.2.1. Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Commercial Products
      • 5.5.3.1. Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pharmaceutical Stability and Storage Services Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2025 & 2033
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. Japan
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. Saudi Arabia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.6. Qatar
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.7. Oman
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Key Participant Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
  • 7.3. Company Profiles
    • 7.3.1. Catalent, Inc
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Almac Group
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Charles River Laboratories
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Eurofins Scientific
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Intertek Group plc
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Lucideon Limited
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Alcami Corporation
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Element Materials Technology
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. BioLife Solutions Inc.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Q1 Scientific
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Reading Scientific Services Ltd.
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Service Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. Roylance Stability Storage Limited
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Service Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. ALS
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Service Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Q Laboratories
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Service Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. Auriga Research Private Limited
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Service Benchmarking
      • 7.3.15.4. Strategic Initiatives
    • 7.3.16. PD Partners
      • 7.3.16.1. Company Overview
      • 7.3.16.2. Financial Performance
      • 7.3.16.3. Service Benchmarking
      • 7.3.16.4. Strategic Initiatives
    • 7.3.17. Precision Stability Storage
      • 7.3.17.1. Company Overview
      • 7.3.17.2. Financial Performance
      • 7.3.17.3. Service Benchmarking
      • 7.3.17.4. Strategic Initiatives
    • 7.3.18. SGS Societe Generale de Surveillance SA.
      • 7.3.18.1. Company Overview
      • 7.3.18.2. Financial Performance
      • 7.3.18.3. Service Benchmarking
      • 7.3.18.4. Strategic Initiatives
Product Code: GVR-4-68039-936-6

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 4 Global Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 5 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 6 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 7 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 8 U.S Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 9 U.S Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 10 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 12 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 13 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 14 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 15 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 16 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 17 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 19 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 20 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 21 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 22 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 23 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 25 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 26 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 27 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 29 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 30 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 31 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 32 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 33 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 36 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 37 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 38 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 40 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 41 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 42 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 44 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 46 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 47 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 48 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 49 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 50 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 51 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 52 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 53 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 54 Middle East & Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 55 Middle East & Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 56 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 57 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 59 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 60 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 61 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 62 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 63 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 64 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 66 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 67 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Pharmaceutical Stability and Storage Services Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Pharmaceutical Stability and Storage Services Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Stability and Storage Services Market: Service movement analysis
  • Fig. 21 Stability Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Other Stability Testing Methods Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Non-Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Pharmaceutical Stability and Storage Services Market: Molecule outlook and key takeaways
  • Fig. 31 Pharmaceutical Stability and Storage Services Market: Molecule movement analysis
  • Fig. 32 Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021-2033 (USD Million)
  • Fig. 40 Key Country Dynamics
  • Fig. 41 U.S. Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key Country Dynamics
  • Fig. 43 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key Country Dynamics
  • Fig. 45 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key Country Dynamics
  • Fig. 50 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key Country Dynamics
  • Fig. 52 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key Country Dynamics
  • Fig. 56 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key Country Dynamics
  • Fig. 60 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key Country Dynamics
  • Fig. 62 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key Country Dynamics
  • Fig. 78 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key Country Dynamics
  • Fig. 80 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 MEA Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key Country Dynamics
  • Fig. 83 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!